STOCK TITAN

Evolent Health Inc Stock Price, News & Analysis

EVH NYSE

Welcome to our dedicated page for Evolent Health news (Ticker: EVH), a resource for investors and traders seeking the latest updates and insights on Evolent Health stock.

Evolent Health Inc (NYSE: EVH) delivers transformative healthcare solutions through value-based care models and AI-powered technology. This news hub provides investors and healthcare professionals with essential updates on the company developments shaping modern care delivery.

Access authoritative coverage of EVH's strategic initiatives including specialty care management advancements, AI-driven clinical review systems, and partnerships with major health systems. Our curated news collection features earnings reports, regulatory filings, and analysis of operational milestones in oncology, cardiology, and musculoskeletal care management.

Key focus areas include updates on Evolent's proprietary platforms for total cost of care optimization, health plan administration innovations, and value-based payment model expansions. Stay informed about technological integrations like the Machinify Auth AI system that streamline clinical decision-making processes.

Bookmark this page for real-time updates on EVH's progress in aligning financial incentives with patient outcomes. Monitor how their integrated approach to population health management continues to redefine care delivery standards across healthcare networks.

Rhea-AI Summary

Evolent Health (EVH) has announced an agreement to acquire certain assets and an exclusive license for Machinify Auth, a proven AI software platform.

This acquisition aims to enhance Evolent's specialty condition management platform through AI-enabled clinical workflow automation.

Machinify's technology uses machine learning, large language models, and data analytics to improve clinical quality, speed, and consistency.

Expected benefits include increased first-pass approvals, streamlined data collection, and reduced clinician workforce time by 55%.

The acquisition, deemed neutral to Adjusted EBITDA in the first year, is expected to close in Q3 2024.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.75%
Tags
-
Rhea-AI Summary

Evolent Health, Inc. (NYSE: EVH) has announced a strategic partnership with digital cancer care platform Careology to enhance cancer care in the U.S. This collaboration aims to provide more coordinated, connected, and empowered journeys for individuals living with cancer. By integrating Careology's digital cancer care technology into Evolent's comprehensive care navigation services, the joint platform will offer personalized information, tools, and support to help patients manage their diagnoses and treatment regimens more effectively. The partnership comes at a important time as global cancer rates are expected to increase significantly, and the U.S. faces challenges such as rising costs and drug shortages in cancer care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.27%
Tags
partnership
-
Rhea-AI Summary

Evolent Health, Inc. announced strong first quarter results, with a revenue increase of 49.6% to $639.7 million and an Adjusted EBITDA of $54.1 million. The company raised its revenue outlook for full year 2024 and reiterated its Adjusted EBITDA guidance. Evolent also highlighted new revenue agreements and an exclusive partnership with Careology. Despite a net loss of $(25.2) million, the CEO remains optimistic about the company's growth potential.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.27%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.37%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.44%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.33%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.61%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.15%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.1%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13.54%
Tags

FAQ

What is the current stock price of Evolent Health (EVH)?

The current stock price of Evolent Health (EVH) is $9.6 as of August 22, 2025.

What is the market cap of Evolent Health (EVH)?

The market cap of Evolent Health (EVH) is approximately 1.0B.
Evolent Health Inc

NYSE:EVH

EVH Rankings

EVH Stock Data

1.04B
115.64M
1.54%
108.92%
16.24%
Health Information Services
Services-management Services
Link
United States
ARLINGTON